Your browser doesn't support javascript.
loading
New Therapies for Treating Hepatitis C Virus: Impact on Laboratory Testing Recommendations and Clinical Management.
Tolan, Nicole V; Horowitz, Gary L; Graham, Camilla S; Hillyard, David; Osburn, William; Ray, Stuart.
Afiliação
  • Tolan NV; Department of Laboratory Medicine and Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA; nicole.tolan@sciex.com.
  • Horowitz GL; Department of Pathology and Laboratory Medicine, Tufts Medical Center and Tufts University School of Medicine, Boston, MA.
  • Graham CS; Assistant Professor of Medicine, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, MA.
  • Hillyard D; Professor of Pathology, University of Utah; Medical Director of the Molecular Hepatitis and Retrovirus and Molecular Infectious Diseases laboratories and the Molecular Infectious Diseases and Molecular Hepatitis/Retrovirus sections, ARUP, Salt Lake City, UT.
  • Osburn W; Assistant Professor of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
  • Ray S; Professor of Medicine and Vice-Chair of Medicine for Data Integrity and Analytics, Johns Hopkins University School of Medicine, Baltimore, MD.
Clin Chem ; 63(12): 1799-1805, 2017 12.
Article em En | MEDLINE | ID: mdl-29018029
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatite C Crônica Tipo de estudo: Guideline / Prognostic_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatite C Crônica Tipo de estudo: Guideline / Prognostic_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article